ID   M3K9_HUMAN              Reviewed;        1104 AA.
AC   P80192; A3KN85; Q0D2G7; Q6EH31; Q9H2N5;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   05-OCT-2010, entry version 106.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 9;
DE            EC=2.7.11.25;
DE   AltName: Full=Mixed lineage kinase 1;
GN   Name=MAP3K9; Synonyms=MLK1, PRKE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   PHOSPHORYLATION AT THR-304; SER-308 AND THR-312, AND MUTAGENESIS OF
RP   LYS-171; THR-304; THR-305; SER-308 AND THR-312.
RX   PubMed=15610029; DOI=10.1021/bi049866y;
RA   Durkin J.T., Holskin B.P., Kopec K.K., Reed M.S., Spais C.M.,
RA   Steffy B.M., Gessner G., Angeles T.S., Pohl J., Ator M.A., Meyer S.L.;
RT   "Phosphoregulation of mixed-lineage kinase 1 activity by multiple
RT   phosphorylation in the activation loop.";
RL   Biochemistry 43:16348-16355(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 53-1104 (ISOFORM 2).
RA   McNee J.J., Dower S.K., Guesdon F.;
RT   "cDNA sequence and gene organisation of mixed lineage kinase 1.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 142-535, AND TISSUE SPECIFICITY.
RC   TISSUE=Colon epithelium;
RX   MEDLINE=93238756; PubMed=8477742;
RX   DOI=10.1111/j.1432-1033.1993.tb17810.x;
RA   Dorow D.S., Devereux L., Dietzsch E., de Kretser T.;
RT   "Identification of a new family of human epithelial protein kinases
RT   containing two leucine/isoleucine-zipper domains.";
RL   Eur. J. Biochem. 213:701-710(1993).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-565, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-529; SER-533; THR-535;
RP   SER-547; SER-552; THR-565; SER-652; SER-693; SER-695; THR-915; SER-917
RP   AND SER-929, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-246; CYS-467; GLN-497 AND CYS-646.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Activates the JUN N-terminal pathway.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Homodimerization via the leucine zipper domains
CC       is required for autophosphorylation and subsequent activation (By
CC       similarity).
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P80192-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P80192-4; Sequence=VSP_013765;
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial tumor cell lines of
CC       colonic, breast and esophageal origin.
CC   -!- PTM: Autophosphorylation on serine and threonine residues within
CC       the activation loop plays a role in enzyme activation. Thr-312 is
CC       likely to be the main autophosphorylation site.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH3 domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI11408.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY327900; AAQ23054.1; -; mRNA.
DR   EMBL; BC111407; AAI11408.1; ALT_INIT; mRNA.
DR   EMBL; BC133706; AAI33707.1; -; mRNA.
DR   EMBL; AF251442; AAG44591.1; -; mRNA.
DR   IPI; IPI00008115; -.
DR   IPI; IPI00179189; -.
DR   PIR; S32467; JU0229.
DR   RefSeq; NP_149132.2; -.
DR   UniGene; Hs.445496; -.
DR   UniGene; Hs.593542; -.
DR   PDB; 3DTC; X-ray; 2.60 A; A=136-406.
DR   PDBsum; 3DTC; -.
DR   ProteinModelPortal; P80192; -.
DR   SMR; P80192; 55-113, 57-415.
DR   STRING; P80192; -.
DR   PhosphoSite; P80192; -.
DR   PRIDE; P80192; -.
DR   Ensembl; ENST00000381250; ENSP00000370649; ENSG00000006432.
DR   GeneID; 4293; -.
DR   KEGG; hsa:4293; -.
DR   UCSC; uc001xml.1; human.
DR   UCSC; uc001xmm.1; human.
DR   CTD; 4293; -.
DR   GeneCards; GC14M071194; -.
DR   H-InvDB; HIX0011779; -.
DR   HGNC; HGNC:6861; MAP3K9.
DR   HPA; HPA000942; -.
DR   MIM; 600136; gene.
DR   PharmGKB; PA30607; -.
DR   eggNOG; prNOG12879; -.
DR   HOVERGEN; HBG067662; -.
DR   OMA; PGAGMLK; -.
DR   OrthoDB; EOG9QC3RC; -.
DR   PhylomeDB; P80192; -.
DR   BRENDA; 2.7.11.25; 247.
DR   BindingDB; P80192; -.
DR   NextBio; 16897; -.
DR   ArrayExpress; P80192; -.
DR   Bgee; P80192; -.
DR   CleanEx; HS_MAP3K9; -.
DR   Genevestigator; P80192; -.
DR   GermOnline; ENSG00000006432; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0004706; F:JUN kinase kinase kinase activity; ISS:UniProtKB.
DR   GO; GO:0004708; F:MAP kinase kinase activity; NAS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0007257; P:activation of JUN kinase activity; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015785; MAPKKK-like.
DR   InterPro; IPR016231; MAPKKK9/10/11.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR011511; SH3_2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   PANTHER; PTHR23257:SF87; MAPKKK-like; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   PIRSF; PIRSF000556; MAPKKK9_11; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50044; SH3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism; Repeat;
KW   Serine/threonine-protein kinase; SH3 domain; Transferase.
FT   CHAIN         1   1104       Mitogen-activated protein kinase kinase
FT                                kinase 9.
FT                                /FTId=PRO_0000086258.
FT   DOMAIN       52    116       SH3.
FT   DOMAIN      144    412       Protein kinase.
FT   DOMAIN      430    451       Leucine-zipper 1.
FT   DOMAIN      465    486       Leucine-zipper 2.
FT   NP_BIND     150    158       ATP (By similarity).
FT   COMPBIAS     12     42       Ala-rich.
FT   COMPBIAS     30     38       Poly-Glu.
FT   COMPBIAS    495    509       Arg/Lys-rich (basic).
FT   COMPBIAS    863    972       Pro-rich.
FT   COMPBIAS   1011   1041       Ser-rich.
FT   ACT_SITE    268    268       Proton acceptor (By similarity).
FT   BINDING     171    171       ATP.
FT   MOD_RES     304    304       Phosphothreonine; by autocatalysis.
FT   MOD_RES     308    308       Phosphoserine; by autocatalysis.
FT   MOD_RES     312    312       Phosphothreonine; by autocatalysis.
FT   MOD_RES     529    529       Phosphothreonine.
FT   MOD_RES     533    533       Phosphoserine.
FT   MOD_RES     535    535       Phosphothreonine.
FT   MOD_RES     547    547       Phosphoserine.
FT   MOD_RES     552    552       Phosphoserine.
FT   MOD_RES     565    565       Phosphothreonine.
FT   MOD_RES     652    652       Phosphoserine.
FT   MOD_RES     693    693       Phosphoserine.
FT   MOD_RES     695    695       Phosphoserine.
FT   MOD_RES     915    915       Phosphothreonine.
FT   MOD_RES     917    917       Phosphoserine.
FT   MOD_RES     929    929       Phosphoserine.
FT   MOD_RES     931    931       Phosphoserine (By similarity).
FT   MOD_RES     934    934       Phosphoserine (By similarity).
FT   MOD_RES     998    998       Phosphoserine (By similarity).
FT   VAR_SEQ     675    675       M -> MALLAASWVVPIDIE (in isoform 2).
FT                                /FTId=VSP_013765.
FT   VARIANT     246    246       A -> V (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040698.
FT   VARIANT     467    467       R -> C (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040699.
FT   VARIANT     497    497       R -> Q (in dbSNP:rs56196343).
FT                                /FTId=VAR_040700.
FT   VARIANT     646    646       Y -> C (in dbSNP:rs34322726).
FT                                /FTId=VAR_040701.
FT   MUTAGEN     171    171       K->A: Loss of kinase activity and
FT                                threonine phosphorylation.
FT   MUTAGEN     304    304       T->A: Reduces threonine phosphorylation.
FT                                Impairs JNK activation.
FT   MUTAGEN     305    305       T->A: Little effect on threonine
FT                                phosphorylation. Mildly impairs JNK
FT                                activation.
FT   MUTAGEN     308    308       S->A: Impairs JNK activation.
FT   MUTAGEN     312    312       T->A: Loss of threonine phosphorylation.
FT                                Strongly impairs JNK activation.
FT   CONFLICT    356    356       A -> R (in Ref. 4).
FT   CONFLICT    433    433       M -> T (in Ref. 1; AAQ23054).
FT   CONFLICT    511    535       KLKDGNRISLPSDFQHKFTVQASPT -> AQPVLPFPHGHS
FT                                RCPGGTGSSWGGQ (in Ref. 4).
FT   STRAND      143    149
FT   STRAND      158    163
FT   STRAND      167    171
FT   HELIX       185    197
FT   STRAND      217    221
FT   HELIX       228    232
FT   HELIX       239    250
FT   HELIX       254    258
FT   STRAND      259    262
FT   HELIX       271    273
FT   STRAND      274    278
FT   STRAND      290    292
FT   HELIX       313    315
FT   HELIX       318    323
FT   HELIX       331    334
FT   HELIX       338    343
FT   TURN        356    358
FT   HELIX       376    385
FT   HELIX       390    392
FT   HELIX       396    404
SQ   SEQUENCE   1104 AA;  121895 MW;  0F059C867FCE7276 CRC64;
     MEPSRALLGC LASAAAAAPP GEDGAGAGAE EEEEEEEEAA AAVGPGELGC DAPLPYWTAV
     FEYEAAGEDE LTLRLGDVVE VLSKDSQVSG DEGWWTGQLN QRVGIFPSNY VTPRSAFSSR
     CQPGGEDPSC YPPIQLLEID FAELTLEEII GIGGFGKVYR AFWIGDEVAV KAARHDPDED
     ISQTIENVRQ EAKLFAMLKH PNIIALRGVC LKEPNLCLVM EFARGGPLNR VLSGKRIPPD
     ILVNWAVQIA RGMNYLHDEA IVPIIHRDLK SSNILILQKV ENGDLSNKIL KITDFGLARE
     WHRTTKMSAA GTYAWMAPEV IRASMFSKGS DVWSYGVLLW ELLTGEVPFR GIDGLAVAYG
     VAMNKLALPI PSTCPEPFAK LMEDCWNPDP HSRPSFTNIL DQLTTIEESG FFEMPKDSFH
     CLQDNWKHEI QEMFDQLRAK EKELRTWEEE LTRAALQQKN QEELLRRREQ ELAEREIDIL
     ERELNIIIHQ LCQEKPRVKK RKGKFRKSRL KLKDGNRISL PSDFQHKFTV QASPTMDKRK
     SLINSRSSPP ASPTIIPRLR AIQLTPGESS KTWGRSSVVP KEEGEEEEKR APKKKGRTWG
     PGTLGQKELA SGDEGSPQRR EKANGLSTPS ESPHFHLGLK SLVDGYKQWS SSAPNLVKGP
     RSSPALPGFT SLMEMEDEDS EGPGSGESRL QHSPSQSYLC IPFPRGEDGD GPSSDGIHEE
     PTPVNSATST PQLTPTNSLK RGGAHHRRCE VALLGCGAVL AATGLGFDLL EAGKCQLLPL
     EEPEPPAREE KKRREGLFQR SSRPRRSTSP PSRKLFKKEE PMLLLGDPSA SLTLLSLSSI
     SECNSTRSLL RSDSDEIVVY EMPVSPVEAP PLSPCTHNPL VNVRVERFKR DPNQSLTPTH
     VTLTTPSQPS SHRRTPSDGA LKPETLLASR SPSSNGLSPS PGAGMLKTPS PSRDPGEFPR
     LPDPNVVFPP TPRRWNTQQD STLERPKTLE FLPRPRPSAN RQRLDPWWFV SPSHARSTSP
     ANSSSTETPS NLDSCFASSS STVEERPGLP ALLPFQAGPL PPTERTLLDL DAEGQSQDST
     VPLCRAELNT HRPAPYEIQQ EFWS
//
